The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $55.48

Today's change-1.00 -1.77%
Updated September 26 4:00 PM EDT. Delayed by at least 15 minutes.
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $55.48

Today's change-1.00 -1.77%
Updated September 26 4:00 PM EDT. Delayed by at least 15 minutes.

Bristol-Myers Squibb Co crosses below 20-day moving average

Bristol-Myers Squibb Co closed sharply lower Monday, dropping (U.S.)$1.00 or 1.77% to (U.S.)$55.48 and crossing below its 20-day moving average. Over the last five days, shares have gained 0.73%, but are down 19.35% for the last year to date. Shares have underperformed the S&P 500 by 19.02% during the last year.

Key company metrics

  • Open(U.S.) $56.26
  • Previous close(U.S.) $56.48
  • High(U.S.) $56.31
  • Low(U.S.) $55.40
  • Bid / Ask(U.S.) $55.53 / (U.S.) $55.65
  • YTD % change-19.35%
  • Volume8,597,622
  • Average volume (10-day)10,022,234
  • Average volume (1-month)12,093,027
  • Average volume (3-month)9,672,497
  • 52-week range(U.S.) $55.02 to (U.S.) $77.12
  • Beta0.72
  • Trailing P/E32.47×
  • P/E 1 year forward21.53×
  • Forward PEG1.10×
  • Indicated annual dividend(U.S.) $1.52
  • Dividend yield2.74%
  • Trailing EPS(U.S.) $1.71
Updated September 26 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue4,8714,3914,2874,069
Total other revenue--------
Total revenue4,8714,3914,2874,069
Gross profit3,6693,3433,3452,987
Total cost of revenue1,2021,0489421,082
Total operating expense3,2102,7414,5823,413
Selling / general / administrative1,2381,0681,5011,176
Research & development1,2661,1361,7561,132
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-329-25738323
Other operating expenses, total-167-254----
Operating income1,6611,650-295656
Interest income (expense), net non-operating-42-43-43-41
Gain (loss) on sale of assets-----174208
Other--------
Income before tax1,6151,655-410987
Income after tax1,1881,206-188730
Income tax, total427449-222257
Net income1,1661,195-197706
Total adjustments to net income--------
Net income before extra. items1,1661,195-197706
Minority interest-22-11-9-24
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,1661,195-197706
Inc. avail. to common incl. extra. items1,1661,195-197706
Diluted net income1,1661,195-197706
Dilution adjustment--------
Diluted weighted average shares1,6791,6801,6701,678
Diluted EPS excluding extraordinary itemsvalue per share0.690.71-0.120.42
Dividends per sharevalue per share0.380.380.380.37
Diluted normalized EPSvalue per share0.550.600.130.30